NCT02527954 is a clinical trial in Male Sterility Due to Y-chromosome Deletions, sponsored by Instituto Valenciano de Infertilidad, IVI Alicante.

Who is sponsoring NCT02527954?

NCT02527954 is sponsored by Instituto Valenciano de Infertilidad, IVI Alicante.

What condition does NCT02527954 study?

NCT02527954 studies Male Sterility Due to Y-chromosome Deletions.

Is NCT02527954 still recruiting?

NCT02527954 is currently terminated. Last updated 8 March 2019.

Last reviewed 2019-03-08 · How we verify

NCT02527954

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions

Terminated Last updated 8 March 2019

What this trial tests

trial in Male Sterility Due to Y-chromosome Deletions in 5 participants. Terminated before completion.

Timeline

22 September 2015

Primary endpoint
11 June 2018

11 June 2018

Quick facts

Lead sponsor	Instituto Valenciano de Infertilidad, IVI Alicante
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	5
Start date	22 September 2015
Primary completion	11 June 2018
Estimated completion	11 June 2018
Sites	3 locations across Spain

Conditions studied

Male Sterility Due to Y-chromosome Deletions — all drugs for Male Sterility Due to Y-chromosome Deletions →

Sponsor

Instituto Valenciano de Infertilidad, IVI Alicante — full company profile →

Who can join

Adults 18 to 50, any sex, with Male Sterility Due to Y-chromosome Deletions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, investigators assess, using Fluorescence in situ Hybridization (FISH) and Comparative Genomic Hybridization (CGH) arrays for Preimplantation Genetic Screening (PGS), the incidence of aneuploidies in spermatozoa and embryos from infertile men with and without microdeletions who undergo assisted reproduction in their clinics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Instituto Valenciano de Infertilidad, IVI Alicante trials

Trials by the same sponsor.

NCT07504575 — Effect of PRP in Donor Semen During Cryoprervation · recruiting
NCT04784260 — Microbiome Influence on Seminal Quality · completed
NCT03741699 — Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH) · Phase 3 · completed
NCT02535377 — Human Sperm Markers of Cryodamage Resistance · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02527954 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Valenciano de Infertilidad, IVI Alicante
Last refreshed: 8 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02527954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing